Saiyed Atiq Raza Sells 12,166 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 12,166 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $10.07, for a total value of $122,511.62. Following the sale, the director now owns 731,560 shares in the company, valued at approximately $7,366,809.20. This trade represents a 1.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Saiyed Atiq Raza also recently made the following trade(s):

• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total transaction of $24,024.00.

Arteris Stock Up 5.9 %

AIP stock opened at $9.48 on Friday. The stock has a market capitalization of $380.88 million, a PE ratio of -9.87 and a beta of 1.25. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The firm has a 50 day moving average of $8.22 and a 200 day moving average of $7.88. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $10.60.

Institutional Trading of Arteris

Institutional investors have recently modified their holdings of the stock. US Bancorp DE acquired a new position in shares of Arteris during the third quarter valued at approximately $34,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris in the second quarter worth approximately $86,000. Algert Global LLC purchased a new stake in shares of Arteris during the second quarter worth approximately $115,000. MetLife Investment Management LLC raised its stake in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris in the 3rd quarter valued at $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.